IPR Loophole… Closed For Now
As far as IPRs are concerned, it doesn’t matter who owns a patent, whether the owner be an Indian tribe or a group of kindergarten students.
Up In Smoke? Sovereign Immunity, IPRs, And Native American Tribes
Tribal sovereign immunity being asserted in IPRs is looking more and more questionable.
How Legisway Helps In-House Teams Manage All Legal Matters In One Trusted Place
Operate with AI driven insights, legal intake, unified content and modular scalability to transform efficiency and clarity.
Perspectives From In-House Counsel: Patent Rights — Who Decides?
Domestic or foreign law, district court or the Patent and Trademark Office, judge or jury? These questions matter.
3 Questions For Unified Patents CEO Post-Oil States (Part II)
Unified’s CEO has graciously agreed to a written interview -- one that’s timely in the immediate aftermath of the Supreme Court’s recent rulings on the constitutionality and implementation of IPRs.
3 Questions For Unified Patents CEO Post-Oil States (Part I)
Unified’s CEO has graciously agreed to a written interview -- one that’s timely in the immediate aftermath of the Supreme Court’s recent rulings on the constitutionality and implementation of IPRs.
SCOTUS Upholds Constitutionality Of System To Challenge Bad Patents
Why should a government agency not be able to correct its own mistakes?
3 Observations From The Federal Circuit Judicial Conference
The Federal Circuit will continue in its efforts to bring uniformity to patent law, and will not shy away from challenges presented by the America Invents Act.
3 Observations From The Patent Administrative Law Conference
This conference proved that companies and IP lawyers require a comprehensive understanding of the IPR process.
Will SCOTUS Uphold The System To Challenge Bad Patents?
Erroneously granted patents do not help anyone and certainly do not further the very purpose of the patent system as set forth by the Constitution.
Why Assigning Patents To Native American Tribes To Avoid Inter Partes Review Is Bad Medicine
Here are three big reasons why, according to IP columnist Tom Kulik.
How Filevine’s New DraftAI Cuts Out Hours Of Writing Work
Now it transforms your document creation with natural language prompts.
3 Questions For IBM’s Chief Patent Counsel
Columnist Gaston Kroub interviews Manny Schecter, a leading voice in the IP community.
A New Patent Loophole? Paying Off A Native American Tribe To Exploit Its Sovereign Immunity
If this tactic is allowed, it will be a big win for Big Pharma -- and a big loss for patients and consumers.
The Fight To Claim A Cure
When the underlying technology is so potentially valuable, companies will go to war on multiple fronts.
Supreme Court, Patent Saviors?
The Supreme Court just agreed to decide a profoundly important question in patent law right now.
Developing The Story Of Patent Litigation: Q&A With Cooley’s Ellen Scordino
This Biglaw partner brings pharma experience to law firm cases.